Elvira Forte

Dr. Elvira Forte

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LTLukas S. Tombor
Lukas S. Tombor
DJDavid John
David John
SGSimone F. Glaser
Simone F. Glaser
GLGuillermo Luxán
Guillermo Luxán
EFElvira Forte
Elvira Forte
DBDittmar Böckler
Dittmar Böckler
Endothelial cells play a critical role in the adaptation of tissues to injury. Tissue ischemia induced by infarction leads to profound changes in endothelial cell functions and can induce transition to a mesenchymal state. Here we explore the kinetics and individual cellular responses of endothelial cells after myocardial infarction by using single cell RNA sequencing. This study demonstrates a time dependent switch in endothelial cell proliferation and inflammation associated with transient changes in metabolic gene signatures. Trajectory analysis reveals that the majority of endothelial cells 3 to 7 days after myocardial infarction acquire a transient state, characterized by mesenchymal gene expression, which returns to baseline 14 days after injury. Lineage tracing, using the Cdh5-CreERT2;mT/mG mice followed by single cell RNA sequencing, confirms the transient mesenchymal transition and reveals additional hypoxic and inflammatory signatures of endothelial cells during early and late states after injury. These data suggest that endothelial cells undergo a transient mes-enchymal activation concomitant with a metabolic adaptation within the first days after myocardial infarction but do not acquire a long-term mesenchymal fate. This mesenchymal activation may facilitate endothelial cell migration and clonal expansion to regenerate the vascular network.

1 March 2020 in Cell Reports
Verified
Journal Article
Open access
EFElvira Forte
Elvira Forte
DSDaniel A. Skelly
Daniel A. Skelly
MCMandy Chen
Mandy Chen
SDSandra Daigle
Sandra Daigle
KMKaesi A. Morelli
Kaesi A. Morelli
MFMilena B. Furtado
Milena B. Furtado
Cardiac ischemia leads to the loss of myocardial tissue and the activation of a repair process that culminates in the formation of a scar whose structural characteristics dictate propensity to favorable healing or detrimental cardiac wall rupture. To elucidate the cellular processes underlying scar formation, here we perform unbiased single-cell mRNA sequencing of interstitial cells isolated from infarcted mouse hearts carrying a genetic tracer that labels epicardial-derived cells. Sixteen interstitial cell clusters are revealed, five of which were of epicardial origin. Focusing on stromal cells, we define 11 sub-clusters, including diverse cell states of epicardial- and endocardial-derived fibroblasts. Comparing transcript profiles from post-infarction hearts in C57BL/6J and 129S1/SvImJ inbred mice, which displays a marked divergence in the frequency of cardiac rupture, uncovers an early increase in activated myofibroblasts, enhanced collagen deposition, and persistent acute phase response in 129S1/SvImJ mouse hearts, defining a crucial time window of pathological remodeling that predicts disease outcome.

4 September 2018 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
EFElvira Forte
Elvira Forte
MFMilena Bastos Furtado
Milena Bastos Furtado
NRNadia A. Rosenthal
Nadia A. Rosenthal

23 February 2021 in Circulation
Verified
Journal Article
Open access
PDF file
EFElvira Forte
Elvira Forte
BPBryant Perkins
Bryant Perkins
ASAmalia Sintou
Amalia Sintou
HKHarkaran S. Kalkat
Harkaran S. Kalkat
APAngelos Papanikolaou
Angelos Papanikolaou
SSSusanne Sattler
Susanne Sattler
Background: Ischemic heart disease is a leading cause of heart failure and despite advanced therapeutic options, morbidity and mortality rates remain high. Although acute inflammation in response to myocardial cell death has been extensively studied, subsequent adaptive immune activity and anti-heart autoimmunity may also contribute to the development of heart failure. After ischemic injury to the myocardium, dendritic cells (DC) respond to cardiomyocyte necrosis, present cardiac antigen to T cells, and potentially initiate a persistent autoimmune response against the heart. Cross-priming DC have the ability to activate both CD4 + helper and CD8 + cytotoxic T cells in response to necrotic cells and may thus be crucial players in exacerbating autoimmunity targeting the heart. This study investigates a role for cross-priming DC in post–myocardial infarction immunopathology through presentation of self-antigen from necrotic cardiac cells to cytotoxic CD8 + T cells. Methods: We induced type 2 myocardial infarction–like ischemic injury in the heart by treatment with a single high dose of the β-adrenergic agonist isoproterenol. We characterized the DC population in the heart and mediastinal lymph nodes and analyzed long-term cardiac immunopathology and functional decline in wild type and Clec9a -depleted mice lacking DC cross-priming function. Results: A diverse DC population, including cross-priming DC, is present in the heart and activated after ischemic injury. Clec9a −/− mice deficient in DC cross-priming are protected from persistent immune-mediated myocardial damage and decline of cardiac function, likely because of dampened activation of cytotoxic CD8 + T cells. Conclusion: Activation of cytotoxic CD8 + T cells by cross-priming DC contributes to exacerbation of postischemic inflammatory damage of the myocardium and corresponding decline in cardiac function. Importantly, this provides novel therapeutic targets to prevent postischemic immunopathology and heart failure.

19 February 2009 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
RGRoberto Gaetani
Roberto Gaetani
Mario LeddaMario Ledda
Mario Ledda
Lucio BarileLucio Barile
Lucio Barile
Isotta ChimentiIsotta Chimenti
Isotta Chimenti
FCFlavia De Carlo
Flavia De Carlo
ALAntonella Lisi
Antonella Lisi
Modulation of cardiac stem cell (CSC) differentiation with minimal manipulation is one of the main goals of clinical applicability of cell therapy for heart failure. CSCs, obtained from human myocardial bioptic specimens and grown as cardiospheres (CSps) and cardiosphere-derived cells (CDCs), can engraft and partially regenerate the infarcted myocardium, as previously described. In this paper we assessed the hypothesis that exposure of CSps and CDCs to extremely low-frequency electromagnetic fields (ELF-EMFs), tuned at Ca2+ ion cyclotron energy resonance (Ca2+-ICR), may drive their differentiation towards a cardiac-specific phenotype. A significant increase in the expression of cardiac markers was observed after 5 days of exposure to Ca2+-ICR in both human CSps and CDCs, as evidenced at transcriptional, translational, and phenotypical levels. Ca2+ mobilization among intracellular storages was observed and confirmed by compartmentalized analysis of Ca2+ fluorescent probes. These results suggest that ELF-EMFs tuned at Ca2+-ICR could be used to drive cardiac-specific differentiation in adult cardiac progenitor cells without any pharmacological or genetic manipulation of the cells that will be used for therapeutic purposes.

1 February 2007 in Nature Clinical Practice Cardiovascular Medicine
Verified
Journal Article
Closed access
Lucio BarileLucio Barile
Lucio Barile
Isotta ChimentiIsotta Chimenti
Isotta Chimenti
RGRoberto Gaetani
Roberto Gaetani
EFElvira Forte
Elvira Forte
FMFabio Miraldi
Fabio Miraldi
AGAlessandro Giacomello
Alessandro Giacomello